Profile for Compugen Ltd. (CGEN)

$ 8.27   0.14 (+1.72%) Volume: 1.01m 4:00 PM EDT 7-Apr-2020
After Hours:  $ 8.27 0.00 (0.00%) Volume: 2.49k 5:17 PM EDT 7-Apr-2020
Business Description:
Compugen Ltd is a therapeutic discovery company. The Company's pipeline consists of early-stage immuno-oncology programs aimed at harnessing the immune system to fight cancer.
Address: 26 Harokmim Street, Building D, Azrieli Center,, Holon, ISR, 5885849
Telephone: +972 37658585 Website: https://www.cgen.com
Facsimile: +972 37658555 Email: N/A
Details
CEO: Anat Cohen-Dayag
Employees: 61 Market Cap: 630.64m
Issue Type: CS
Auditor: Kost Forer Gabbay & Kasierer
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1119774
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: N/A
SIC: